#Sweden #Lund #Clinical Research #Lund Sweden #TFS HealthScience

TFS HealthScience Unveils New Global Brand Identity

In a significant announcement on October 5, 2026, TFS HealthScience, a prominent clinical research organization (CRO) based in Lund, Sweden, has launched a fresh brand identity encapsulated by the new slogan: "Securing the path from science to life." This identity reaffirms TFS’s dedication to collaborating with biotechnology, pharmaceutical, and medtech sponsors across more than 40 countries, ensuring that their approach is characterized by radical honesty, scientific urgency, therapeutic depth, and a commitment to maintaining consistent teams throughout clinical trials.

New Brand, Same Commitment

The company’s CEO, Markus Granlund, expressed enthusiasm about the launch, stating, “Our new brand shows exactly who we are and where we are going. We secure the path from science to life and we do that with a great team that goes above and beyond to make it happen.” This reflection of TFS's core values is designed to communicate their operational philosophy clearly.

TFS HealthScience, founded in 1996, has consistently prioritized how clinical research should be conducted, emphasizing transparency and urgency at every stage of the process. The organizational model of TFS focuses heavily on embedding expert teams within projects, ensuring that the same professionals are involved in a given study from the initial stages up until the completion of data analysis.

Key Features of the New Identity

The new brand identity includes four clear commitments that TFS pledges to its sponsors:

1. Radical Honesty: TFS promises to deliver straightforward and unambiguous communication regarding data, identifying critical issues early on.
2. Scientific Urgency: With clinical leads responsible for significant decisions, sponsors can expect rapid advancements without unnecessary chains of escalation.
3. Therapeutic Depth: Focusing on five key therapeutic areas—dermatology, internal medicine, neuroscience, oncology, and ophthalmology—ensures that team members possess deep knowledge of the relevant indications from the start of each study.
4. Teams That Stay: Remarkably, 88% of TFS's teams remain engaged for the entire duration of a study, which is significantly higher than the industry average.

These commitments are intended not only to enhance operational integrity but also to align the services provided with the specific needs and expectations of sponsors.

Operational Efficiency

TFS HealthScience offers flexible options for collaboration, enabling sponsors to choose between full-service delivery, embedded resources, or a hybrid approach. This adaptability is formed around a sponsor's internal capabilities and outsourcing requirements, aiming to streamline processes and enhance efficiency.

Conclusion

With its new brand identity, TFS HealthScience signifies a forward-thinking approach in the realm of clinical research. Their dedication to maintaining high standards, providing clear communication, and fostering enduring teams solidifies their commitment to advancing healthcare through rigorous scientific inquiry. Learn more about their services and approach at tfscro.com.

By reinforcing their mission to connect science and life, TFS HealthScience is poised for significant impact in the clinical research industry as it strives to ensure that innovative therapies reach the patients who need them most.